Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 05, 2022

BUY
$57.72 - $65.01 $17,316 - $19,503
300 New
300 $19,000
Q4 2021

Feb 14, 2022

SELL
$64.88 - $73.64 $19,464 - $22,092
-300 Closed
0 $0
Q2 2021

Jul 22, 2021

BUY
$63.47 - $69.35 $15,994 - $17,476
252 Added 525.0%
300 $21,000
Q1 2021

May 04, 2021

BUY
$60.0 - $68.46 $2,880 - $3,286
48 New
48 $3,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Better Money Decisions, LLC Portfolio

Follow Better Money Decisions, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Better Money Decisions, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Better Money Decisions, LLC with notifications on news.